TY - JOUR
T1 - Alopecia Areata Is Associated with Atopic Diathesis
T2 - Results from a Population-Based Study of 51,561 Patients
AU - Kridin, Khalaf
AU - Renert-Yuval, Yael
AU - Guttman-Yassky, Emma
AU - Cohen, Arnon D.
N1 - Publisher Copyright:
© 2020 American Academy of Allergy, Asthma & Immunology
PY - 2020/4/1
Y1 - 2020/4/1
N2 - Background: Evidence of TH1/IFN-γ overactivation as a major pathogenic driver somewhat conflicts with data supporting robust allergic background in patients with alopecia areata (AA). Previous investigations of immunological dysregulations show that both TH1- and TH2-related markers are overexpressed in AA. Clinical correlations in large populations may shed light on the immune pathways most likely to result in the clinical phenotype of AA. Objective: To investigate the atopic comorbidities among patients with AA in a large population-based study. Methods: This is a cross-sectional retrospective study of patients with AA and a matched comparison group, analyzing the associations between AA and 4 atopic comorbidities: asthma, atopic dermatitis (AD), allergic rhinitis, and allergic conjunctivitis. χ2 and t tests were used for univariate analysis, and logistic regression model was used for multivariate analysis. The study was performed using the computerized database of the Clalit Health Services, encompassing more than 4.4 million subjects. Results: The study population included 51,561 patients with AA and 51,410 matched control subjects. The prevalence of asthma (7.8% vs 6.5%; odds ratio [OR], 1.22; 95% CI, 1.17-1.28; P <.001), AD (3.9% vs 2.6%; OR, 1.55; 95% CI, 1.44-1.66; P <.001), allergic rhinitis (16.0% vs 12.8%; OR, 1.29; 95% CI, 1.25-1.34; P <.001), and allergic conjunctivitis (23.5% vs 19.6%; OR, 1.27; 95% CI, 1.23-1.30; P <.001) was significantly higher among patients with AA as compared with matched control subjects. Patients with AA also had a significantly higher probability of having more than 1 atopic comorbidity, with increasing OR as the number of concomitant atopic conditions increased. Conclusions: Our analysis supports the previous literature and provides strong generalizability of significant atopy in patients with AA, suggesting TH2 pathogenicity in AA, and challenging the traditional view of AA as a single-axis, TH1-centered disease.
AB - Background: Evidence of TH1/IFN-γ overactivation as a major pathogenic driver somewhat conflicts with data supporting robust allergic background in patients with alopecia areata (AA). Previous investigations of immunological dysregulations show that both TH1- and TH2-related markers are overexpressed in AA. Clinical correlations in large populations may shed light on the immune pathways most likely to result in the clinical phenotype of AA. Objective: To investigate the atopic comorbidities among patients with AA in a large population-based study. Methods: This is a cross-sectional retrospective study of patients with AA and a matched comparison group, analyzing the associations between AA and 4 atopic comorbidities: asthma, atopic dermatitis (AD), allergic rhinitis, and allergic conjunctivitis. χ2 and t tests were used for univariate analysis, and logistic regression model was used for multivariate analysis. The study was performed using the computerized database of the Clalit Health Services, encompassing more than 4.4 million subjects. Results: The study population included 51,561 patients with AA and 51,410 matched control subjects. The prevalence of asthma (7.8% vs 6.5%; odds ratio [OR], 1.22; 95% CI, 1.17-1.28; P <.001), AD (3.9% vs 2.6%; OR, 1.55; 95% CI, 1.44-1.66; P <.001), allergic rhinitis (16.0% vs 12.8%; OR, 1.29; 95% CI, 1.25-1.34; P <.001), and allergic conjunctivitis (23.5% vs 19.6%; OR, 1.27; 95% CI, 1.23-1.30; P <.001) was significantly higher among patients with AA as compared with matched control subjects. Patients with AA also had a significantly higher probability of having more than 1 atopic comorbidity, with increasing OR as the number of concomitant atopic conditions increased. Conclusions: Our analysis supports the previous literature and provides strong generalizability of significant atopy in patients with AA, suggesting TH2 pathogenicity in AA, and challenging the traditional view of AA as a single-axis, TH1-centered disease.
KW - Allergic conjunctivitis
KW - Allergic rhinitis
KW - Alopecia areata
KW - Asthma
KW - Atopic dermatitis
KW - Atopy
KW - Big data
KW - Comorbidities
KW - Population-based
UR - http://www.scopus.com/inward/record.url?scp=85080091545&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2020.01.052
DO - 10.1016/j.jaip.2020.01.052
M3 - Article
C2 - 32036002
AN - SCOPUS:85080091545
SN - 2213-2198
VL - 8
SP - 1323-1328.e1
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 4
ER -